SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-25-004427
Filing Date
2025-01-10
Accepted
2025-01-10 16:01:12
Documents
15
Period of Report
2025-01-10
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d915597d8k.htm   iXBRL 8-K 27737
2 EX-4.1 d915597dex41.htm EX-4.1 88409
6 GRAPHIC g915597g14b44.jpg GRAPHIC 9674
  Complete submission text file 0001193125-25-004427.txt   268912

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA olma-20250110.xsd EX-101.SCH 2832
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE olma-20250110_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE olma-20250110_pre.xml EX-101.PRE 10800
17 EXTRACTED XBRL INSTANCE DOCUMENT d915597d8k_htm.xml XML 3508
Mailing Address 780 BRANNAN STREET SAN FRANCISCO CA 94103
Business Address 780 BRANNAN STREET SAN FRANCISCO CA 94103 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

IRS No.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39712 | Film No.: 25522812
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)